National Neuroscience Institute

The National Neuroscience Institute (NNI) is Singapore's national specialist and regional centre for conditions affecting the brain, spine, nerves and muscles. Its published clinical scope includes stroke, dementia, Parkinson's disease, brain tumours and brain injuries (NNI, About NNI, rechecked 12 September 2026). NNI is a specialist institution within Singapore's public healthcare landscape, not the Ministry of Health itself and not a single-site institute.

Clinical network and patient care

NNI says it operates from seven hospitals: Changi General Hospital, KK Women's and Children's Hospital, Khoo Teck Puat Hospital, Sengkang General Hospital, Singapore General Hospital, Tan Tock Seng Hospital and Woodlands Hospital (NNI, About NNI, rechecked 12 September 2026). Its specialist departments include Neurology, Neurosurgery, Neuroradiology, Neurodiagnostic and Neuroscience Clinical Laboratories, with doctors, nurses and allied-health professionals working across disciplines (NNI, About NNI, rechecked 12 September 2026). The seven-hospital footprint is an operating network description, not a count of separate national institutes or a guarantee that every service is available at every listed hospital.

NNI's services cover diagnosis, treatment and specialist referral for neurological conditions. Its neuroradiology service includes diagnostic and neuro-interventional imaging, including a 24-hour stroke-imaging service and endovascular therapy (NNI, About NNI, rechecked 12 September 2026). Individual patients still require appropriate clinical assessment and referral pathways; the institute's national-centre role should not be interpreted as a diagnosis or treatment recommendation for a particular person.

Research and education

NNI combines patient care with research and education. Its stated research programmes include Alzheimer's disease and related dementia, brain injury and neurotrauma, movement disorders and neurodegenerative diseases, neuro-oncology and neurotechnology (NNI, About NNI, rechecked 12 September 2026). NNI also collaborates with the National University of Singapore and Duke-NUS Medical School in neuroscience education: students from both medical schools are posted to NNI Neurology departments for clinical teaching. It provides continuing medical education in neuroscience for healthcare professionals in Singapore and the region and uses an inter-professional approach to learning (NNI, About NNI, rechecked 12 September 2026). These are education and research functions alongside care, not a separate patient entitlement or a requirement that every patient participate in research or teaching.

Institutional history and relationship to SingHealth

NNI officially began operations on 1 June 1999, after its establishment brought together clinical neuroscience services and research resources; in 2001 it integrated the relevant Tan Tock Seng Hospital and Singapore General Hospital neuroscience resources (NNI, Our History, rechecked 12 September 2026). NNI identifies itself as a member of Singapore Health Services (SingHealth) and the SingHealth Duke-NUS Academic Medical Centre (NNI, About NNI, rechecked 12 September 2026). This relationship distinguishes NNI's specialist institute role from the wider healthcare-cluster role of SingHealth and from the policy role of the Ministry of Health.

Research institute and service boundaries

NNI’s clinical network and its research infrastructure are related but not interchangeable. NNI states that the National Neuroscience Research Institute Singapore (NNRIS) is a joint institute of NNI and Duke-NUS Medical School, bringing together expertise, programmes and research facilities (NNI, About NNI, rechecked 12 September 2026). That joint institute does not turn every NNI hospital location into a research campus or make research participation part of ordinary patient care. Likewise, NNI’s national specialist designation describes its role in Singapore’s neuroscience system; it does not mean that it replaces general practitioners, regional hospitals, MOH, or SingHealth’s other hospitals and specialty centres. Clinical access, appointments, referrals and treatment decisions remain service-specific and patient-specific (NNI, Our Services, rechecked 12 September 2026).